Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Sell
39
GNGBY Quote, Financials, Valuation and Earnings
Last price:
$16.34
Seasonality move
:
0.07%
Day range:
$16.25 - $16.45
52-week range:
$14.84 - $22.85
Dividend yield:
2.46%
P/E ratio:
27.75x
P/S ratio:
1.39x
P/B ratio:
1.48x
Volume:
111.1K
Avg. volume:
69.1K
1-year change:
-24.14%
Market cap:
$4.5B
Revenue:
$3B
EPS (TTM):
$0.59
Analysts' Opinion
-
Consensus RatingGetinge AB has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Getinge AB has an estimated downside of -- from its current price of $16.34.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $16.34.
Fair Value
-
According to the consensus of 0 analysts, Getinge AB has -- downside to fair value with a price target of -- per share.
GNGBY vs. S&P 500
-
Over the past 5 trading days, Getinge AB has overperformed the S&P 500 by 0.29% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Getinge AB does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Getinge AB has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Getinge AB reported revenues of $758.4M.
Earnings Growth
-
Getinge AB earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Getinge AB reported earnings per share of $0.00.
Enterprise value:
5.1B
EV / Invested capital:
--
Price / LTM sales:
1.39x
EV / EBIT:
17.62x
EV / Revenue:
1.61x
PEG ratio (5yr expected):
1.26x
EV / Free cash flow:
20.83x
Price / Operating cash flow:
18.06x
Enterprise value / EBITDA:
10.47x
Gross Profit (TTM):
$1.5B
Return On Assets:
3.01%
Net Income Margin (TTM):
5.01%
Return On Equity:
5.33%
Return On Invested Capital:
4.37%
Operating Margin:
4.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.9B | $2.9B | $3.2B | $705.2M | $758.4M | |
| Gross Profit | $1.4B | $1.3B | $1.5B | $332.9M | $342.7M | |
| Operating Income | $397.9M | $360.1M | $322.6M | $131.9M | $32.7M | |
| EBITDA | $584.8M | $547.4M | $490.1M | $184.4M | $83M | |
| Diluted EPS | $1.04 | $0.78 | $0.59 | $0.30 | $0.00 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.1B | $1.7B | $1.6B | $1.8B | $1.6B | |
| Total Assets | $5.4B | $4.9B | $4.7B | $4.9B | $5.9B | |
| Current Liabilities | $216.7M | $317.5M | $170.8M | $922.2M | $1.5B | |
| Total Liabilities | $2.9B | $2.2B | $1.9B | $2B | $2.9B | |
| Total Equity | $2.5B | $2.7B | $2.8B | $2.9B | $3B | |
| Total Debt | $1.2B | $513.6M | $377.9M | $497M | $905.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $412.4M | $263.3M | $372.5M | $130.3M | $70.4M | |
| Cash From Investing | -$203.9M | -$165M | -$884.6M | -$32.4M | -$302.2M | |
| Cash From Financing | -$229.1M | -$44.3M | $212.9M | -$13.6M | $223.6M | |
| Free Cash Flow | $302.9M | $133.9M | $246.5M | $100.1M | $37.4M | |
GNGBY
Sector
Market Cap
$4.5B
$49.2M
Price % of 52-Week High
71.51%
48.57%
Dividend Yield
2.46%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-24.14%
-30.94%
Beta (5-Year)
0.768
0.754
Dividend yield:
2.46%
Annualized payout:
$0.41
Payout ratio:
74.43%
Growth streak:
4 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$16.33
200-day SMA
Sell
Level
$18.71
Bollinger Bands (100)
Sell
Level
16.19 - 20.93
Chaikin Money Flow
Buy
Level
4.4M
20-day SMA
Buy
Level
$15.95
Relative Strength Index (RSI14)
Buy
Level
53.67
ADX Line
Buy
Level
38.76
Williams %R
Neutral
Level
-25.6198
50-day SMA
Sell
Level
$16.45
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
2.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9622)
Buy
CA Score
(Annual)
Level (0.3991)
Buy
Beneish M-Score
(Annual)
Level (-2.3558)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.9118)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Stock Forecast FAQ
In the current month, GNGBY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GNGBY average analyst price target in the past 3 months is --.
-
Where Will Getinge AB Stock Be In 1 Year?
According to analysts, the consensus estimate is that Getinge AB share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Getinge AB?
Analysts are divided on their view about Getinge AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Getinge AB is a Sell and believe this share price will rise from its current level to --.
-
What Is Getinge AB's Price Target?
The price target for Getinge AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GNGBY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Getinge AB is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GNGBY?
You can purchase shares of Getinge AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Getinge AB shares.
-
What Is The Getinge AB Share Price Today?
Getinge AB was last trading at $16.34 per share. This represents the most recent stock quote for Getinge AB. Yesterday, Getinge AB closed at $16.34 per share.
-
How To Buy Getinge AB Stock Online?
In order to purchase Getinge AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
How High Can Palantir Stock Go?
Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
